CS
NUVA

Cannell & Spears’s NuVasive, Inc. NUVA Stock Holding History

Cannell & Spears’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,012
Closed -$204K – 252
2021
Q2 		$204K Buy
+3,012
New +$206K 0.01% 231
2021
Q1 		– Sell
-3,715
Closed -$209K – 247
2020
Q4 		$209K Buy
+3,715
New +$183K 0.02% 219

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Cannell & Spears's NUVA Position: Q3 2021 in Review

Cannell & Spears sold out of NuVasive, Inc. (NUVA) in Q3 2021, closing a stake of 3,012 shares — an estimated $204K sold.

Cannell & Spears first reported a position in NUVA in Q4 2020 and held it in 2 quarters. The position peaked at $209K in Q4 2020. 250 funds tracked by Wall St. Rank hold NUVA as of Q3 2021.

  • Cannell & Spears reported no remaining NuVasive, Inc. position as of Q3 2021 after selling out during the quarter.
  • Cannell & Spears sold 3,012 NuVasive, Inc. shares in Q3 2021, an estimated $204K.
  • Cannell & Spears first reported a position in NuVasive, Inc. in Q4 2020 and held it in 2 quarters.
  • Cannell & Spears's NuVasive, Inc. position peaked at $209K in Q4 2020.
  • 250 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2021.

Based on Cannell & Spears's 13F filing for Q3 2021, filed 15 Nov 2021.